Balance Sheet for PPCB - findataslice
 Propanc Biopharma, Inc.
Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014Q2-CY2014Q1-CY2014Q4-CY2013
Balance Sheet Date2025-Jun-302025-Mar-312024-Dec-312024-Sep-302024-Jun-302024-Mar-312023-Dec-312023-Sep-302023-Jun-302023-Mar-312022-Dec-312022-Sep-302022-Jun-302022-Mar-312021-Dec-312021-Sep-302021-Jun-302021-Mar-312020-Dec-312020-Sep-302020-Jun-302020-Mar-312019-Dec-312019-Sep-302019-Jun-302019-Mar-312018-Dec-312018-Sep-302018-Jun-302018-Mar-312017-Dec-312017-Sep-302017-Jun-302017-Mar-312016-Dec-312016-Sep-302016-Jun-302016-Mar-312015-Dec-312015-Sep-302015-Jun-302015-Mar-312014-Dec-312014-Sep-302014-Jun-302014-Mar-312013-Dec-31
Fiscal PeriodQ4-FY2025Q3-FY2025Q2-FY2025Q1-FY2025Q4-FY2024Q3-FY2024Q2-FY2024Q1-FY2024Q4-FY2023Q3-FY2023Q2-FY2023Q1-FY2023Q4-FY2022Q3-FY2022Q2-FY2022Q1-FY2022Q4-FY2021Q3-FY2021Q2-FY2021Q1-FY2021Q4-FY2020Q3-FY2020Q2-FY2020Q1-FY2020Q4-FY2019Q3-FY2019Q2-FY2019Q1-FY2019Q4-FY2018Q3-FY2018Q2-FY2018Q1-FY2018Q4-FY2017Q3-FY2017Q2-FY2017Q1-FY2017Q4-FY2016Q3-FY2016Q2-FY2016Q1-FY2016Q4-FY2015Q3-FY2015Q2-FY2015Q1-FY2015Q4-FY2014Q3-FY2014Q2-FY2014
Total Assets19,631,808$22,527,352$78,533$63,644$72,365$37,337$241,907$180,371$60,328$143,742$108,022$94,254$81,651$169,460$110,177$62,165$13,101$28,043$40,616$77,554$98,518$63,938$65,425$197,663$101,652$259,916$712,597$82,775$71,387$110,746$129,081$162,512$95,069$44,786$135,838$181,395$379,142$1,623,115$1,507,988$305,121$627,068$309,624$52,940$51,572$113,745$40$11,923$
Total Current Assets8,352,816$9,736,052$17,984$21,534$25,441$12,855$210,824$145,804$19,039$96,575$54,226$37,862$15,030$144,506$84,878$56,408$6,596$18,518$23,183$54,070$69,022$31,500$20,788$147,835$91,132$248,602$388,055$73,031$60,890$99,287$116,882$149,707$81,976$31,212$122,538$166,672$362,767$1,617,750$1,502,711$299,914$621,890$308,816$52,940$51,572$113,745$40$11,923$
Cash and Cash Equivalents93,241$24,476$19,396$4,067$133,885$73,616$45,817$2,255$14,439$67,007$14,588$4,513$87,799$40$736$
Receivables
Other Current Assets1,380$1,312$1,406$
Assets Held for Sale in Short Term
Total Noncurrent Assets11,278,992$12,791,300$60,549$42,110$46,924$24,482$31,083$34,567$41,289$47,167$53,796$56,392$66,621$24,954$25,299$5,757$6,505$9,525$17,433$23,484$29,496$32,438$44,637$49,828$10,520$11,314$324,542$9,744$10,497$11,459$12,199$12,805$13,093$13,574$13,300$14,723$16,375$5,365$5,277$5,207$5,178$808$0$0$0$0$0$
Goodwill
Other Intangible Assets
Physical Assets50$160$302$634$1,083$1,437$2,023$2,706$3,118$3,593$4,255$4,843$5,422$5,541$5,747$5,648$7,137$7,475$8,417$9,183$8,505$7,573$8,277$9,152$9,854$10,453$10,790$11,283$11,141$12,423$12,527$3,678$3,671$3,672$3,494$808$0$
Other Noncurrent Assets
Assets Held for Sale in Long Term
Total Liabilities5,725,616$4,435,060$4,237,292$4,171,729$3,851,424$3,736,854$3,805,506$3,169,630$3,177,507$3,085,156$3,023,439$2,861,789$3,105,300$3,116,880$3,040,370$2,368,795$3,080,674$3,031,721$3,648,657$3,313,023$3,739,943$4,910,845$5,737,409$4,739,395$4,402,888$3,672,938$4,616,633$5,640,819$6,823,307$6,883,660$7,278,401$6,900,034$5,536,820$4,759,552$3,976,490$1,985,349$2,944,435$5,143,988$4,863,852$3,487,465$3,680,584$2,160,595$1,930,189$1,835,953$1,522,059$1,165,234$1,062,344$
Total Current Liabilities5,578,240$4,341,147$4,154,964$4,101,244$3,792,782$3,687,984$3,762,251$3,133,113$3,158,229$3,060,217$2,992,554$2,822,426$3,062,981$3,116,880$3,040,370$2,368,795$3,080,674$3,031,721$3,648,657$3,313,023$3,739,943$4,890,800$5,714,315$4,717,234$4,402,888$3,672,939$4,616,633$5,640,819$6,823,307$6,883,660$7,278,401$6,900,034$5,536,820$4,759,552$3,976,490$1,985,349$2,944,435$5,143,988$4,863,852$3,487,465$3,680,584$2,160,595$1,930,189$1,835,953$1,522,059$1,165,234$1,062,344$
Accounts Payable1,249,596$1,121,834$1,223,254$1,238,589$1,213,335$1,187,714$1,157,691$1,081,316$966,718$918,195$914,491$899,225$943,023$967,213$920,692$826,184$1,002,335$950,131$1,019,507$929,828$842,156$959,971$917,337$854,954$1,062,609$1,134,120$1,157,369$1,209,688$1,439,162$606,985$483,513$50,000$441,769$326,096$370,093$159,323$107,134$303,127$236,466$291,028$88,092$48,836$350,004$332,287$311,455$
Short Term Debt
Short Term Capital Lease Obligations21,185$21,102$14,516$20,605$7,833$14,744$19,957$25,072$7,290$14,216$19,132$
Other Current Liabilities
Total Noncurrent Liabilities147,376$93,913$82,328$70,485$58,642$48,870$43,255$36,517$19,278$24,939$30,885$39,363$42,319$0$0$0$0$0$0$0$0$20,045$23,094$22,161$0$(1$)0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
Long Term Debt537,921$438,578$409,799$381,789$399,325$582,951$687,650$397,443$390,539$519,718$913,641$926,438$1,075,702$972,670$584,608$624,583$950,180$1,209,186$1,029,688$1,557,734$2,711,173$2,934,340$2,547,085$1,657,377$2,067,717$2,789,624$3,758,891$4,699,299$4,514,921$4,417,450$4,653,437$3,479,845$2,651,423$1,202,523$
Long Term Capital Lease Obligations24,939$30,885$39,363$42,319$20,045$23,094$22,161$
Other Noncurrent Liabilities
Total Equity13,906,192$18,092,292$(4,158,759$)(4,108,085$)(3,779,059$)(3,699,517$)(3,563,599$)(2,989,259$)(3,117,179$)(2,941,414$)(2,915,417$)(2,767,535$)(3,023,649$)(2,947,420$)(2,930,193$)(2,306,630$)(3,067,573$)(3,003,678$)(3,608,041$)(3,235,469$)(3,641,425$)(4,846,908$)(5,671,985$)(4,541,732$)(4,301,236$)(3,413,022$)(3,904,036$)(5,558,044$)(6,751,920$)(6,772,914$)(7,149,320$)(6,737,522$)(5,441,751$)(4,714,766$)(3,840,652$)(1,803,954$)(2,565,293$)(3,520,873$)(3,355,864$)(3,182,344$)(3,053,516$)(1,850,971$)(1,877,249$)(1,784,381$)(1,408,314$)(1,165,194$)(1,050,421$)
Equity to Minority
Equity to Common Shareholders13,906,192$18,092,292$(4,158,759$)(4,108,085$)(3,779,059$)(3,699,517$)(3,563,599$)(2,989,259$)(3,117,179$)(2,941,414$)(2,915,417$)(2,767,535$)(3,023,649$)(2,947,420$)(2,930,193$)(2,306,630$)(3,067,573$)(3,003,678$)(3,608,041$)(3,235,469$)(3,641,425$)(4,846,908$)(5,671,985$)(4,541,732$)(4,301,236$)(3,413,022$)(3,904,036$)(5,558,044$)(6,751,920$)(6,772,914$)(7,149,320$)(6,737,522$)(5,441,751$)(4,714,766$)(3,840,652$)(1,803,954$)(2,565,293$)(3,520,873$)(3,355,864$)(3,182,344$)(3,053,516$)(1,850,971$)(1,877,249$)(1,784,381$)(1,408,314$)(1,165,194$)(1,050,421$)
Additional Paid-In Capital138,243,652$138,212,659$61,878,549$61,132,262$61,696,049$61,237,446$61,018,603$60,851,382$60,311,502$57,068,986$57,696,390$57,800,241$57,364,690$56,319,693$55,614,865$55,444,574$54,074,110$53,007,522$52,018,649$51,105,811$50,913,893$48,879,086$47,766,162$46,400,877$45,713,322$44,805,892$43,729,392$41,081,318$38,214,213$37,211,109$35,555,722$33,795,889$32,980,420$31,972,357$30,137,809$28,968,668$27,671,552$23,415,658$21,360,201$17,901,198$17,458,745$16,903,399$16,753,398$16,657,087$16,374,781$16,374,780$16,374,780$
Retained Earnings(125,621,520$)(121,550,059$)(67,482,713$)(67,052,530$)(66,698,220$)(66,339,642$)(65,797,142$)(65,178,173$)(64,684,732$)(63,878,972$)(63,069,163$)(62,564,423$)(61,557,893$)(60,398,419$)(59,698,343$)(58,804,968$)(58,199,466$)(57,028,696$)(56,610,958$)(56,207,315$)(55,781,770$)(56,985,758$)(54,400,096$)(52,532,987$)(51,041,047$)(49,439,508$)(48,857,652$)(47,407,614$)(45,282,678$)(43,860,251$)(42,369,245$)(40,167,266$)(38,243,523$)(36,610,031$)(35,238,905$)(31,477,992$)(30,376,023$)(27,518,541$)(25,366,632$)(21,804,565$)(20,965,671$)(19,139,084$)18,681,696$18,336,217$(17,552,917$)
Treasury Stock46,477$46,477$46,477$46,477$46,477$46,477$46,477$46,477$46,477$46,477$46,477$46,477$46,477$46,477$46,477$46,477$46,477$46,477$46,477$46,477$46,477$46,477$46,477$46,477$46,477$46,477$46,477$46,477$46,477$46,477$46,477$46,477$46,477$
Capital Lease Obligations62,126$7,833$14,744$19,957$25,072$27,335$37,310$41,293$